Recent News

Australia’s banking regulator warned that frontier AI could make cyberattacks larger, faster, and harder for bank boards to oversee.

The FDA’s proposed limits on bulk compounding of GLP-1 drugs put safety, access, pricing, and pharma market power into the same public-trust fight.

Congress extended a contested FISA surveillance authority through June 12, proving again how easily emergency patches preserve state power while reform gets deferred.

Trump’s voluntary AI data-center energy pledge exposes the real bottleneck: households see higher power bills while tech companies race for constrained grid capacity.

CBS reports the Coast Guard is in crisis during the DHS shutdown. A government that can fund missions but not basic obligations is not disciplined; it is structurally broken.

The FDA says domestic infant formula samples showed very low contaminant levels. The real challenge is turning that result into durable trust after years of supply shocks and institutional confusion.

Google’s Gemini privacy controls show how AI platform power works: make the default easy, make the opt-out confusing, and call the result user choice.

The House advanced a three-year FISA 702 extension without a warrant requirement, leaving Americans with process checks instead of real privacy protection.

CMS wants states to recheck high-risk Medicaid providers, but the accountability test is whether fraud control protects patients or disrupts fragile home care.

Alphabet investors are asking how Google controls government use of its cloud and AI systems before surveillance risk becomes a business model problem.